Survivors of Acute Stanford B (DeBakey III) in Holland: a patient-cantered follow-up indicating that the treatment strategy did not influence quality of life.
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Descending Thoracic Aorta
Long Term Health Related Quality of Life After Acute Type B Aortic Dissection: A Cross Sectional Survey Study
September 12, 2023
Updated JCS/JSCVS/JATS/JSVS 2020 Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection
September 5, 2023
This is the latest (third) version of Guideline on Diagnosis and Treatment of Aortic Aneurysm and Aortic Dissection
Association Between Fluoroquinolone Use and Hospitalization with Aortic Aneurysm or Aortic Dissection
August 24, 2023
The risk of dissection associated with fluoroquinolone use has gained wide acceptance, but recent data indicate there’s more to the story. Pasternak and colleagues report a Swedish, multicenter, propensity-matched study of one million treatment episodes examining the relationship between fluoroquinolone use and aneurysm or dissection.
April 26, 2023
On April 21, Dr. Randy Moore at the University of Calgary in Canada performed the first implantation of Terumo's new hybrid graft, Thoracoflo, in North America for thoracoabdominal aortic aneurysm repair.
2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
November 3, 2022
On November 2, 2022, the American College of Cardiology (ACC) and American Heart Association (AHA) published an update to the 2010 ACC/AHA Guidelines for the Diagnosis and Management of Aortic Disease. The top ten take-home messages are:
October 6, 2022
In conducting the largest study to date supporting the current medical consensus that recommends surgery only for patients with a thoracic aneurysm that is 5.5 centimeters or larger, the authors found that the overall risk for patients below that standard is low.
Total Aortic Arch Replacement Using a Frozen Elephant Trunk Device: Results of a One-Year US Multicenter Trial
September 9, 2022
The authors of this study reported the safety and one-year clinical outcomes of the Thoraflex Hybrid frozen elephant trunk prosthesis from the US Investigational Device Exemption trial. Follow-up was available in 63 of 65 patients from twelve centers at one-year, when the mortality was 11 percent (7/65), and freedom was 81 percent (51/63) from major
May 20, 2022
This is a compreshensive review on the experience with use of TEVAR in patients with Marfan syndrome, including durablity, complications, and timing, etc. Drs. Steinmetz and Cosellihe also discussed the role and trend of TEVAR in Marfan paitents with aortic disease.
May 18, 2022
Gripping vignette of a fatal case of renocardiac pathologies. The stills from the (sadly non-contrast) CTA are most interesting.
April 20, 2022
On April 20, 2020, Terumo Aortic announced that the US FDA has granted approval for the Thoraflex Hybrid frozen elephant trunk prothesis. This is the first FET prosthesis commercially available in the US and will bring a new viable treatment option for patients with diseases of the aortic arch and descending aorta.